Patent Assignment
Reel/Frame 006169/0092
Assignment of Assignors Interest.
Recorded: 1992-08-03
Pages: 2
Assignors
SCHUBERT, HANS-PETER
Executed: 1992-07-16
GROME, JOHN J.
Executed: 1992-07-16
KITTNER, BARBARA
Executed: 1992-07-16
RUDOLPHI, KARL
Executed: 1992-07-16
GEBERT, ULRICH
Executed: 1992-07-16
Assignee
HOECHST AKTIENGESELLSCHAFT
A CORP. OF THE FED. REP. OF GERMANY, D-6230 FRANKFURT AM MAIN 80, GERMANY
Covered Property
(1)
Xanthine Derivatives for the Treatment of Secondary Nerve Cell Damage and Functional Disorders After Cranio-Cerebral Traumas
Patent:
5,409,935 →
Application:
07/909,389 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Aug 18, 2000
From: HOECHST MARION ROUSSEL DEUTSCHLAND GMBH
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 011019/0234 →
Assignment of Assignor's Interest
Mar 26, 2002
From: HOECHST AKTIENGESELLSCHAFT (HOECHST AG)
To: AVENITS PHARMA DETUSCHLAND GMBH (AVENTIS PHARMA)
Reel/Frame 012721/0315 →
Change of Name
Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Assignment of Assignor's Interest
Jul 15, 2009
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: SOLACE PHARMACEUTICALS INC.
Reel/Frame 022960/0109 →
Security Agreement
Nov 6, 2009
From: SOLACE PHARMACEUTICALS INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 023471/0973 →
Release of Security Interest
Nov 3, 2011
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: SOLACE PHARMACEUTICALS INC.
Reel/Frame 027169/0426 →